<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Health and Related Research</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D5A2BD8A-6362-40C2-BBF3-31D7B45C7547"><gtr:id>D5A2BD8A-6362-40C2-BBF3-31D7B45C7547</gtr:id><gtr:firstName>Andrea</gtr:firstName><gtr:surname>Manca</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C4A6769B-9BBD-41A8-95BE-5B6030382277"><gtr:id>C4A6769B-9BBD-41A8-95BE-5B6030382277</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Hamilton</gtr:otherNames><gtr:surname>Jackson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9A8719EF-1443-472E-A62B-A75637FCBCCC"><gtr:id>9A8719EF-1443-472E-A62B-A75637FCBCCC</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:otherNames>Rowland</gtr:otherNames><gtr:surname>Abrams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0AE055BD-6FA1-4B6A-B784-B9A9159C3B14"><gtr:id>0AE055BD-6FA1-4B6A-B784-B9A9159C3B14</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>FitzGerald</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E0E3BC95-63DC-4C44-B2D4-E835E5A60DBF"><gtr:id>E0E3BC95-63DC-4C44-B2D4-E835E5A60DBF</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Stevens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1C5B9CC8-1DB2-4507-8061-DA08A98994B2"><gtr:id>1C5B9CC8-1DB2-4507-8061-DA08A98994B2</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:surname>Bojke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E5515A4A-3DDA-4476-A398-AA5AAD207BD1"><gtr:id>E5515A4A-3DDA-4476-A398-AA5AAD207BD1</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Tappenden</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/31A16DAB-ABB2-49AA-823C-5384AE58FED1"><gtr:id>31A16DAB-ABB2-49AA-823C-5384AE58FED1</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Latimer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6BD7FAEB-ED63-4505-9880-6F450C9918EF"><gtr:id>6BD7FAEB-ED63-4505-9880-6F450C9918EF</gtr:id><gtr:firstName>A</gtr:firstName><gtr:surname>Brennan</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A28FB5BF-2C3C-46AD-BB85-1202594D3B9F"><gtr:id>A28FB5BF-2C3C-46AD-BB85-1202594D3B9F</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Palmer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902159"><gtr:id>2EE33C78-A665-4596-BA98-6DB02900D4EA</gtr:id><gtr:title>Methods of extrapolating RCT evidence for economic evaluation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0902159</gtr:grantReference><gtr:abstractText>Treatment costs and benefits have to estimated when they are unknown beyond a certain time period, and the appropriate time the costs or benefits last is judged by NICE to be longer. This may add uncertainty to NICE s decison making process about whether or not the treatment should be funded, as there are usually various ways of obtaining these estimates. The research project will review and compare the different approaches and recommend the best ways of undertaking the estimation for different situations.</gtr:abstractText><gtr:technicalSummary>Extrapolation of evidence over time is common in work which informs the NICE decision-making process on cost-effectiveness of health technologies. Although a variety of methods and approaches to extrapolation are used, little research has been conducted into the effect of this methodology on the decision process. This research will review the current methodology for extrapolation used in health economic modelling and develop a taxonomy of methods and approaches. The resulting categories will be critically reviewed using a set of structural uncertainty criteria developed for the purpose. The results will be illustrated using case-studies which will be selected for the particular analyses that need to be demonstrated. The results of this research will be reported and synthesised for dissemination in typical scientific forums.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>313888</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Health Economics and Decision Science Seminar in the School of Health and Related Research at University of Sheffield</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9EC682AC-DAF5-42E2-96E4-BB2C156AD164</gtr:id><gtr:impact>Kate Ren gave a talk on an alternative approach to extrapolate treatment effects given published Kaplan-Meier curves with around 40 participants. There was a good 15 minutes questions and discussion time.

Presented an alternative method and there was a lot of interests in the presentations.</gtr:impact><gtr:outcomeId>tdfGyUVod4d</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NICE Methods Guide Update 2012</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>99C63C9C-804E-47CC-AFD9-348F53C473DA</gtr:id><gtr:impact>Contributions to the NICE methods guide update committee on survival modelling by John Stevens and presentation on adjusting for crossover by Nick Latimer. Input, drafting and co-authorship of the sections in the new NICE methods guide on survival modelling and crossover by Prof Steve Palmer and Nick Latimer

Material added to this guidance which is read and used by every pharmaceutical company and medical device manufacturer that submits to NICE for approval of its health technology to be used in the NHS in England and Wales.</gtr:impact><gtr:outcomeId>sRpjjxdNqMi</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>12260</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Network of Hubs for Trials Methodology Research: Workshops, Small projects, Other Hub Network Events</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>161D55F8-B32A-4869-99FD-4AB7F816525A</gtr:id><gtr:outcomeId>58cabb00804965.82939098</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE Methods Guide Update 2012</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>25D388D6-C0E7-479E-A666-4FB505C5E027</gtr:id><gtr:impact>Contributions to the NICE methods guide update committee on survival modelling by John Stevens and presentation on adjusting for crossover and Nick Latimer respectively
 
Input, drafting and co-authorship of the sections in the new NICE methods guide on survival modelling and crossover by Prof Steve Palmer and Nick Latimer
 
Impact - Material added to this guidance which is read and used by every pharmaceutical company and medical device manufacturer that submits to NICE for approval of its health technology to be used in the NHS in England and Wales.</gtr:impact><gtr:outcomeId>iRNWN5zYJXe</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE DSU Cancer Modelling Master Class</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D3316B2-5C1B-404E-9B07-085DB7991472</gtr:id><gtr:impact>People attending were from NICE - the technical analysts and their senior managers. The knowledge and skills imparted should widen the knowledge base of survival analysis methods and options in this key regulatory body in the UK.</gtr:impact><gtr:outcomeId>bL5KNeGXQU1</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Pharmacoeconomics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>899552AA-BEE6-4319-9F06-D3314904710F</gtr:id><gtr:outcomeId>JmmG2yZTYR9</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Data Extraction Database on Methods of Extrapolation used in around 180 Heath technology Assessment reports</gtr:description><gtr:id>753C8F6B-3815-469E-9D9D-F552CA2D8508</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>bnjQHKpTCmW</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Data Extraction on Methods of Extrapolation</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A structured listing of methods which might be used to extraplate RCT evidence for health technology assessments</gtr:description><gtr:id>1C0A40DA-D87C-406F-8408-5F6FC121CDAF</gtr:id><gtr:impact>None as yet
Plan to use to provide recommendations to pharma companies submitting to NICE and reimbursement authorities world-wide</gtr:impact><gtr:outcomeId>irMnYw9piHC</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Taxonomy of Extrapolation Methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>45F9B3F8-B764-44A5-BD1F-B34849E70CB3</gtr:id><gtr:title>Survival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a9e997fce306b1457bafd15788be3b3"><gtr:id>7a9e997fce306b1457bafd15788be3b3</gtr:id><gtr:otherNames>Latimer NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>TCjDX5g2oWN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B38EC68-E6B4-41DA-9A88-4ABE2D5808A3</gtr:id><gtr:title>Issues in Extrapolation: Modelling progression-free survival and other interval censored time to event data</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a0984a1af29cc700a84853df812d59"><gtr:id>35a0984a1af29cc700a84853df812d59</gtr:id><gtr:otherNames>Stevens John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>M1CeQbsD8Dx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3AB0CE1-D33A-403E-B8DB-6047FB462BEC</gtr:id><gtr:title>Methods for modelling competing risks in time to event data: using bivariate and multistate time-to-event models for extrapolation of RCT evidence.</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a0984a1af29cc700a84853df812d59"><gtr:id>35a0984a1af29cc700a84853df812d59</gtr:id><gtr:otherNames>Stevens John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>cK4cyDfxiXK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2EBCC03-DC5D-4821-AB17-96CED37C5BC8</gtr:id><gtr:title>Uncertainty in extrapolation: how can current methods characterise different structural uncertainties</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/296892cd7f22723de088ab0b02ca4ba7"><gtr:id>296892cd7f22723de088ab0b02ca4ba7</gtr:id><gtr:otherNames>Bojke Laura</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>AxCPSzMiaqF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>426C0942-BAD2-4423-8F3E-FCE34F99C5E5</gtr:id><gtr:title>The impact of alternative extrapolation methods for TTE data in an evaluation of the RITA3 trial for acute coronary syndrome.</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9001bdc33ae3ff2d5e7ab2150a360cca"><gtr:id>9001bdc33ae3ff2d5e7ab2150a360cca</gtr:id><gtr:otherNames>Mahon Ronan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>rtgqCJ6HR4M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D844BB9-351E-4A7F-AACB-33724A66FD16</gtr:id><gtr:title>Lessons learned from a review of methods used to extrapolate longitudinal measures of disease severity, disability and risk factors beyond the RCT evidence horizon in HTA</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09c8800f7fa39eb0fb2293e9f41af54e"><gtr:id>09c8800f7fa39eb0fb2293e9f41af54e</gtr:id><gtr:otherNames>Brennan Alan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>DQXRYDgribR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E8839AC-BF2F-4419-95AD-42B3FA4C92CB</gtr:id><gtr:title>Use of external sources to calibrate time-to-event models when undertaking extrapolation. A set of recommendations</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d12ed3d7ed41e5cbfdeed1c5a4e4afd3"><gtr:id>d12ed3d7ed41e5cbfdeed1c5a4e4afd3</gtr:id><gtr:otherNames>Jackson Chris</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>UkewH4F7jQf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>743BC6AF-AF09-40B5-8FC4-E98AD233DE37</gtr:id><gtr:title>Project Report for Methods of extrapolating RCT evidence for economic evaluation</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09c8800f7fa39eb0fb2293e9f41af54e"><gtr:id>09c8800f7fa39eb0fb2293e9f41af54e</gtr:id><gtr:otherNames>Brennan Alan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>sYd62ZcFRCT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E69D571F-EF89-4C3A-A574-5FF584C1C8CC</gtr:id><gtr:title>Accounting for uncertain events when extrapolating over time in health economic decision models</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f04299318e4cf52359032b3c9e64a454"><gtr:id>f04299318e4cf52359032b3c9e64a454</gtr:id><gtr:otherNames>Palmer Stephen</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>JBHafs9pBq1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A6F4BBF-C4F2-44EC-80E3-5A3B3AD6E896</gtr:id><gtr:title>A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.</gtr:title><gtr:parentPublicationTitle>Journal of public health (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d8ce86d07dd85f3c9da72d7f0533de4"><gtr:id>0d8ce86d07dd85f3c9da72d7f0533de4</gtr:id><gtr:otherNames>Breeze P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-3842</gtr:issn><gtr:outcomeId>56df0c21d14f77.76496999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16D7EEF3-6ED4-4CCF-B97D-755C3672F62F</gtr:id><gtr:title>Extrapolating Survival from Randomized Trials Using External Data: A Review of Methods.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e34e78f3be6717209b698907c5d8f735"><gtr:id>e34e78f3be6717209b698907c5d8f735</gtr:id><gtr:otherNames>Jackson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>56e1955c857445.92562957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC933CEC-7444-4BEB-9D23-4C594C04AA13</gtr:id><gtr:title>An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/822bb257943f471eb4d3d6c990afd037"><gtr:id>822bb257943f471eb4d3d6c990afd037</gtr:id><gtr:otherNames>Watson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>54648c9ab59263.84767432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83C519F4-37A2-4CE5-801D-712CEBEA4175</gtr:id><gtr:title>Lessons learned from a review of methods used to directly extrapolate costs and utilities in health economic decision models.</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/839462db2b87435fe2cd849e94e452fe"><gtr:id>839462db2b87435fe2cd849e94e452fe</gtr:id><gtr:otherNames>Manca Andrea</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>DPa3vYWiKmM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DFAA4FD-630C-4AE5-8961-406F1A65F2D0</gtr:id><gtr:title>Selecting a measure of effect size for evidence synthesis of time to event data: comparison of hazard ratio, relative risk, odds ratio and the difference in mean/median survival time</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a0984a1af29cc700a84853df812d59"><gtr:id>35a0984a1af29cc700a84853df812d59</gtr:id><gtr:otherNames>Stevens John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>tgKGG123k3S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E5F85F9-CDFD-4C63-835B-7A6C3D80B39D</gtr:id><gtr:title>Issues in Extrapolation: Approaches to survival extrapolation with a single time-to-event data set</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a0984a1af29cc700a84853df812d59"><gtr:id>35a0984a1af29cc700a84853df812d59</gtr:id><gtr:otherNames>Stevens John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>YbjG2FiZiHA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67271A45-7166-45A3-A226-026FDB0E3443</gtr:id><gtr:title>Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a9e997fce306b1457bafd15788be3b3"><gtr:id>7a9e997fce306b1457bafd15788be3b3</gtr:id><gtr:otherNames>Latimer NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>54648e7ae99373.39269561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F392BB4-AD71-474D-9586-22C116BBD832</gtr:id><gtr:title>Evaluation of alternative methods to use when only Kaplan Meier Data is available for modelling and extrapolating time-to-event data.</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35a0984a1af29cc700a84853df812d59"><gtr:id>35a0984a1af29cc700a84853df812d59</gtr:id><gtr:otherNames>Stevens John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>eUcBi8Ld1bc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCB680B6-365B-4010-BC66-D8414E6A8F97</gtr:id><gtr:title>Extrapolating long-term disability over time with limited evidence: A case study in Psoriatic Arthritis</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/296892cd7f22723de088ab0b02ca4ba7"><gtr:id>296892cd7f22723de088ab0b02ca4ba7</gtr:id><gtr:otherNames>Bojke Laura</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>iTNpMd4CgyZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>568AC466-D841-44D7-886E-C8BF93F49658</gtr:id><gtr:title>Survival extrapolation in the presence of cause specific hazards.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845665cb9899c2c569a59c3b93056cf7"><gtr:id>845665cb9899c2c569a59c3b93056cf7</gtr:id><gtr:otherNames>Benaglia T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>54648ac4f273a8.39885050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DC0330F-33FD-4A4E-9E98-2145FFC40962</gtr:id><gtr:title>The potential for longitudinal data modelling approaches to extrapolating RCT evidence on disease severity, disability and risk factors over time in cost-effectiveness models</gtr:title><gtr:parentPublicationTitle>Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09c8800f7fa39eb0fb2293e9f41af54e"><gtr:id>09c8800f7fa39eb0fb2293e9f41af54e</gtr:id><gtr:otherNames>Brennan Alan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>qANCycXoTwu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01C28106-D633-4448-B66D-DFE948D0AE80</gtr:id><gtr:title>Adjusting overall survival for treatment switches: commonly used methods and practical application.</gtr:title><gtr:parentPublicationTitle>Pharmaceutical statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbf1eec6cd4086a5933790173b0a9904"><gtr:id>cbf1eec6cd4086a5933790173b0a9904</gtr:id><gtr:otherNames>Watkins C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1539-1604</gtr:issn><gtr:outcomeId>doi_15963_2_pst_1602</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>035940DA-F8B1-4E23-AE6F-1EBD2F23B3B1</gtr:id><gtr:title>Issues in extrapolation of RCT evidence in HTA: what are the problems and why do they matter?</gtr:title><gtr:parentPublicationTitle>?</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9001bdc33ae3ff2d5e7ab2150a360cca"><gtr:id>9001bdc33ae3ff2d5e7ab2150a360cca</gtr:id><gtr:otherNames>Mahon Ronan</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>WSvsLEo6uH7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902159</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>237CBF0D-6B87-46FD-A97B-E432D87D3FE6</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.2  Health and welfare economics</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>